Search - tctmd.com

Displaying 121 - 140 of 222

Sort: Relevancy | Date

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 387: Saftey of Protamine Adminstration After Percutaneous Left Atrial Appendage Occlusion

Presenter: Ahmed El Shaer

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

Presentation TCT 2022

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Presenter: Gauravpal Singh Gill

September 18, 2022

Presentation TCT 2022

TCT 385: Outcomes of Same day Compared to Next day Discharge for Patients Undergoing Left Atrial Appendage Occlusion

Presenter: Riaz Mahmood

September 18, 2022

Presentation TCT 2022

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

Presenter: Jennifer Rymer

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

Presentation TCT 2022

TCT 382: Cardiac Computed Tomographic Assessment of Residual Left Atrial Appendage Patency Following Left Atrial Appendage Closure

Presenter: Sung-Han Yoon

September 18, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

Presentation TCT 2022

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

Presenter: Anders Kramer

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation

TCT 405: Predictive Computational Modeling of THV Under-Expansion and Late Balloon Aortic Valvuloplasty to Treat THV Dysfunction

Presenter: Janarthanan Sathananthan

September 17, 2022

Advertisement

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

TCT 387: Saftey of Protamine Adminstration After Percutaneous Left Atrial Appendage Occlusion

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

TCT 385: Outcomes of Same day Compared to Next day Discharge for Patients Undergoing Left Atrial Appendage Occlusion

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

TCT 382: Cardiac Computed Tomographic Assessment of Residual Left Atrial Appendage Patency Following Left Atrial Appendage Closure

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

Recent Clinical Trials & Registries: Update 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

TCT 405: Predictive Computational Modeling of THV Under-Expansion and Late Balloon Aortic Valvuloplasty to Treat THV Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content